Bruce Brener, MD
Vascular Surgery · Livingston, NJNPI 1053317636
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,853 of the $17,601 with a category attached, or 73.0%. It is spread thinly across 27 manufacturers, the largest accounting for just 21.4%. Reporting peaked in 2024 at $5,518 and has fallen 70.1% since, to $1,652 in 2025.
Across 136 payments — averaging $129.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$4K
- Endologix LLC$3K
- Siemens Medical Solutions USA, Inc.$1K
- Inari Medical, Inc.$1K
- Philips North America LLC$1K
- Penumbra, Inc.$1K
- plus $6K from 21 others
Across 30 payments — averaging $1488.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bolton Medical Inc$39K
- Cook Research Incorporated$6K
What the payments were for
- Travel & lodging$4,74727%
- Food & beverage$12,85373%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 27 | $3,759 |
| Endologix LLC | 6 | $2,890 |
| Siemens Medical Solutions USA, Inc. | 12 | $1,399 |
| Inari Medical, Inc. | 9 | $1,315 |
| Philips North America LLC | 8 | $1,074 |
| Penumbra, Inc. | 8 | $1,063 |
| Medtronic(2 entities) | 10 | $911 |
| Cook Medical LLC | 9 | $859 |
| Silk Road Medical, Inc. | 6 | $768 |
| Boston Scientific | 6 | $439 |
| Limflow Inc. | 3 | $352 |
| Cardiovascular Systems Inc. | 3 | $341 |
| Bolton Medical Inc | 2 | $300 |
| Bard Peripheral Vascular, Inc. | 2 | $274 |
| Cvrx, Inc. | 2 | $271 |
| KCI USA, Inc. | 2 | $259 |
| Convatec Inc. | 2 | $236 |
| Smith+Nephew | 2 | $192 |
| Angiodynamics, Inc. | 2 | $186 |
| Tactile Systems Technology Inc | 4 | $180 |
| Johnson & Johnson | 4 | $153 |
| Acera Surgical, Inc. | 1 | $153 |
| EKOS Corporation | 1 | $107 |
| Haemonetics Corporation | 1 | $36 |
| Pfizer | 2 | $32 |
| Imperative Care, Inc | 1 | $31 |
| Lemaitre Vascular, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alto Abdominal Stent Graft System$2,054
- Artis pheno$1,209
- ENROUTE Transcarotid Neuroprotection System$1,082
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,078
- GORE TAG Thoracic Endoprosthesis$1,041
- FLOWTRIEVER CATHETER, S$1,033
- CT THROMBECTOMY SYSTEM KIT$1,033
- Indigo System$947
- ENROUTE Transcarotid Stent$676
- GORE TAG Thoracic Branch Endoprosthesis$540
- GORE VIABAHN VBX Balloon Expandable Endo$461
- Torus Stent Graft System$429
- ENDOCROSS Device$429
- Ovation$407
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$406
- Azurion 7 M20$397
- Diamondback Peripheral$299
- Zenith Spiral-Z$283
- IN.PACT Admiral$278
- Azurion 7 M12$277
How this compares
$17,601 in reported general payments places this provider in the 80th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $11,321 |
| ClopidogrelClopidogrel Bisulfate | 18 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $32 | $11,32120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Livingston
- Cindy SturtLivingston$17K
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Laurel HastingsCamden$98K
- Danielle PinedaPomona$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.